| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Terren S. Peizer | Director, 10%+ Owner | $40,203,076 | 23 Nov 2022 | ||
| Jonathan Adams | EVP Liver Cirrhosis Programs | $82,185 | 02 Feb 2022 | ||
| PENELOPE MARKHAM | EVP Liver Cirrhosis R&D | $80,851 | 16 Feb 2023 | ||
| STEVE GORLIN | Director | $78,345 | 09 Nov 2023 | ||
| CHRISTOPHER READING | EVP Neuroscience R&D | $62,780 | 16 Feb 2023 | ||
| CLARENCE AHLEM | EVP Neuroscience Product Dev. | $62,780 | 16 Feb 2023 | ||
| RICHARD J. BERMAN | Director | $19,265 | 20 Nov 2024 | ||
| CUONG DO V. | President & CEO, Director | $16,187 | 05 Jan 2026 | ||
| Joseph M. Palumbo | Chief Medical Officer | 05 Jan 2026 | |||
| SIGMUND ROGICH | Director | 05 Jan 2026 | |||
| Amy Suzon Chappell | Director | 05 Jan 2026 | |||
| Michael Edward Sherman | Director | 05 Jan 2026 | |||
| Robert J. Hariri | Director | 20 Nov 2024 | |||
| James Paul Lang | Director | 05 Jan 2026 | |||
| Kameel D. Farag | Director | 05 Jan 2026 | |||
| JOANNE WENDY KIM | Chief Financial Officer | 05 Jan 2026 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|